Volume | 470,838 |
|
|||||
News | - | ||||||
Day High | 0.5591 | Low High |
|||||
Day Low | 0.4988 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Novo Integrated Sciences Inc | NVOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.544 | 0.4988 | 0.5591 | 0.519 | 0.5256 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
878 | 470,838 | US$ 0.5280926 | US$ 248,646 | - | 0.416 - 5.384 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:30 | formt | 10,000 | US$ 0.529 | USD |
Novo Integrated Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.23M | 17.75M | - | 12.57M | -13.22M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Novo Integrated Sciences News
Date | Time | Source | News Article |
---|---|---|---|
4/15/2024 | 15:30 | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 Second.. |
4/11/2024 | 16:00 | Business Wire | Novo Integrated Sciences Closes on $6,210,000 Securities.. |
3/26/2024 | 13:30 | Business Wire | Novo Integrated Sciences Provides Update on Certain Current.. |
2/21/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
2/21/2024 | 15:05 | Business Wire | Novo Integrated Sciences Subsidiary, Clinical Consultants.. |
2/20/2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2/20/2024 | 13:00 | Business Wire | Novo Integrated Sciences Receives Limited Waiver to.. |
2/16/2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2/16/2024 | 13:00 | Business Wire | Novo Integrated Sciences Appoints New President |
2/15/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2/06/2024 | 11:00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
1/22/2024 | 15:31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVOS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.468 | 0.5747 | 0.416 | 0.500927 | 963,042 | 0.061 | 13.03% |
1 Month | 0.485 | 0.65 | 0.416 | 0.5173497 | 1,085,073 | 0.044 | 9.07% |
3 Months | 0.74 | 0.8349 | 0.416 | 0.5860272 | 751,506 | -0.211 | -28.51% |
6 Months | 3.01 | 3.445 | 0.416 | 1.81 | 3,042,989 | -2.48 | -82.43% |
1 Year | 1.065 | 5.384 | 0.416 | 2.40 | 18,065,640 | -0.536 | -50.33% |
3 Years | 23.50 | 33.20 | 0.416 | 2.20 | 8,688,356 | -22.97 | -97.75% |
5 Years | 45.00 | 149.80 | 0.416 | 2.58 | 8,269,308 | -44.47 | -98.82% |
Novo Integrated Sciences Description
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. It has two reportable segments: healthcare services and product manufacturing and development. |